Clinical study to determine accuracy of test device in low blood oxygen level.
Completed
- Conditions
- Other general symptoms and signs,
- Registration Number
- CTRI/2019/06/019933
- Lead Sponsor
- AmZetta Technologies Pvt Ltd
- Brief Summary
The SpO2 probe is designed for non-invasive spot-check of arterial oxygen saturation (SpO2) and pulse rate for the intended operator (patient/user) in a home, hospital or clinical environment.
The purpose of trial is to determine the accuracy of the test device as per the specified standard.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
- Subject is willing to give written informed consent for participation in the study.
- Healthy Male or Female, between 18-45 years of age.
- Subject willing to undergo controlled desaturation.
- Subject in a general healthy state with no evidence of ongoing medication and ongoing illness that effect the participation into the study.
- At least 2 darkly pigmented subjects or 15% of the subject pool, whichever is larger will be recruited into the study.
Exclusion Criteria
- Subject has any deformity at sensor site location 2.
- Pregnant women or nursing mothers 3.
- Subject has known respiratory condition 4.
- Subject has known cardiovascular disease 5.
- Subjects with known clotting disorders (self-reported) history of bleeding disorders or personal history of prolonged bleeding from injury, history of blood clots, haemophilia, current use of blood thinner: prescription or daily use of aspirin.
- Subject on psychotropic drugs 7.
- Subject with Diabetes 8.
- Subject with artificial nails or nail polish 9.
- Subject with Raynaud’s disease 10.
- Critically ill individuals 11.
- Smokers 12.
- Subjects with Haemoglobin <9 g/dL- Self reported 13.
- Subjects with carboxyhemoglobin levels larger than 3% 15.
- The subject has another health condition which in the opinion of the principal investigator makes him/her unsuitable for testing.
- Self-reported health conditions as identified in the Health Assessment Form (self-reported), diabetes, thyroid disease, kidney disease / chronic renal impairment, history of seizures (except childhood febrile seizures), epilepsy, history of unexplained syncope, recent history of frequent migraine headaches, recent head injury, cancer / chemotherapy.
- Subject participating in any other clinical trial or have had participated in any clinical trial within last 3 months or is on a follow up for any clinical trial.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The values obtained from the test device will be compared by the test values obtained by the co-oximeter and statistical analysis will be done as per the EVS-EN ISO 80601-2-61:2011. same day
- Secondary Outcome Measures
Name Time Method Ease of use of test device will be determined as per the list of questionnaires. same day
Trial Locations
- Locations (1)
Sanjivani Super speciality hospital
🇮🇳Ahmadabad, GUJARAT, India
Sanjivani Super speciality hospital🇮🇳Ahmadabad, GUJARAT, IndiaDr Gaurav H ChhayaPrincipal investigator9825324056gaurav.chhaya2010@yahoo.com